EARLY YEARS
B orn in New Delhi, India to an Indian Air Force officer and a loving homemaker wife. His early childhood was significantly limited by severe bronchial asthma, and affected attendance in kindergarten and primary school. During middle school, Dr. Chaturvedi fell in love with calculus, Sanskrit, Vedic philosophy, art, and the sciences. His childhood and teenage years were joyous, humble, loving, and he enjoyed nature and friends at different Air Force base schools as his father transferred during his tenure. During high school, Dr. Chaturvedi moved to New Delhi.
During high school, at 16, in a new urban environment, didactic education was challenging. The love for organic chemistry, mathematics, and physics took firm root, all over again Dr. Chaturvedi, after being accepted to the prestigious St. Stephens College of Delhi University to pursue an honors course in chemistry. Instead of conceptual learning during middle school, didactic learning and frameworks in college became attractive. In large part, this was because of the simple beauty of logic in Richard Feynman's The Feynman Lectures on Physics. While deriving quantum thermodynamics and quantum mechanics equations from first principles in undergraduate lectures, Dr. Chaturvedi took to the possibility of variations in the sacrosanct ”fundamental“ Planck's and Gravitational constants. Here started a lifelong pursuit of creating an analytical framework for the study of living and inorganic matter. Taken in by a famous quote from E.F. Schumaker, in his book Small is Beautiful: A Study of Economics As If People Mattered.—"Any intelligent fool can make things bigger, more complex, and more violent. It takes a touch of genius–and a lot of courage to move in the opposite direction." Dr. Chaturvedi has dedicated the last forty years towards a passionate pursuit of simplicity, beauty in mathematics, physics, and indeed all things "life".
During medical school, Dr. Chaturvedi researched factors contributing to mechanical aspects of exacerbation of bronchial asthma at the Patel Chest Institute. He enjoyed his surgery rotations and a yearlong stint in the Department of Cardiology at the reputed superspecialty G.B. Pant Institute in New Delhi as well. Dr. Chaturvedi immigrated to the United States in 1990 to begin his internship at Good Samaritan Hospital—a teaching program of Johns Hopkins Medical School. He then received residency and fellowship training from the hospitals of Johns Hopkins Medical School, Tufts University Medical School, and Harvard Medical School. Dr. Chaturvedi later went on to practice medicine from 1995 to 1999 at Faulkner Hospital in Boston.
HARVARD MEDICAL SCHOOL
A s a clinical fellow and junior staff at the Department of Medicine, VAMC in West Roxbury, Massachusetts, USA, Dr. Chaturvedi engaged in research with Dr. Christopher Cannon, M.D. at the cardiac cath lab; with Dr. G.V.R.K. Sharma, M.D.; and Dr. Daniel Pietro, M.D. at the cardiac echo lab, at the Department of Cardiology at the VA. Additionally, Dr. Chaturvedi worked on research projects in clinical epidemiology with Dr. Kim Eagle, M.D. at the Department of Cardiology at the Massachusetts General Hospital, Boston, and with Dr. Natesa Pandian at the cardiac echocardiography laboratory, Department of Cardiology at Tufts University Medical Center. In 1995, the United States Government awarded Dr. Chaturvedi for his work at the Department of Medicine with Dr. Peter Tishler, M.D. PhD., and at the Department of Psychiatry with Dr. Ming Tsuang, M.D., PhD. at Harvard Medical School and the VA. Dr. Chaturvedi's research has been presented at the annual conference of the American College of Cardiology and published in peer-reviewed journals. During his residency years in Internal Medicine, Dr Chaturvedi developed a strong interest in cardiac echocardiography and completed a two year residency program at Faulkner Hospital, then a teaching program of the Tufts University School of Medicine. He continued to pursue cardiac echocardiography in the animal laboratory at Tufts University Medical Center. Dr. Chaturvedi developed a novel frame-grabber approach to study wall motion abnormalities and applied modified Fourier transforms to detect predictors of the onset and worsening of congestive heart failure in post-myocardial infarction patients.
SYNGERISTIC ACEI AND BETA BLOCKADE
A n emerging consensus on free-radical mediated mechanisms of myocardial injury during the early 90s was being widely studied. Dr. Chaturvedi was amongst the first in the world to postulate and prove that ACE Inhibitors were protective in myocardial ischemia, even without the presence of reduced left ventricular ejection fraction and symptomatic congestive heart failure. When combined with beta-blockers, in a retrospective study of over 3000 veterans, Dr. Chaturvedi showed a significant myocardial protective effect, while calcium channels alone were attributable to worsened mortality in CAD patients. This was presented in the 1995 annual proceedings of the American College of Cardiology. It would take several years to be proven in the well-regarded prospective trial—"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients"—led by Dr. Salim Yusuf which was published in the New England Journal of Medicine in 2000.
ACTIVITY BASED COMPUTING PROTOCOL (ABCP)
I n 1997, Dr. Chaturvedi invented "Activity-Based Computing Protocol", a socket-based, OS-independent enterprise computation framework to be used in a tokenized data transfer across stakeholders in a health care delivery system. ABCP is now being used to deploy a concept of stream-trading in financial markets and settling payments between digital wallets of a new digital token framework—U.
2001 NUSPEECH COMMUNICATIONS
I n 1999, Dr. Chaturvedi was the first in the world to demonstrate the live conversion of switch-based SS-7 signaled telephone calls into stream enabled, indexed data directly into a patient's medical record. Subsequently, Dr. Chaturvedi and his team integrated these live audio feeds from a doctors' dictation into a fully functional electronic medical record software–NuSpeech PowerSpace— complete with DICOM interfaces to MRI, digital Xray machines and diagnostic testing. Powerspace was deployed in production at medical practices and hospitals in New Jersey and Massachusetts, USA.
2005 PHYSICIAN MEDICAL CENTERS
I n 2004, Dr. Chaturvedi developed a concept of providing affordable integrated medical care to a community. Heavily influenced with technology, computational models for providing efficient care, Dr. Chaturvedi developed mHQ, an index of human health which represented a computational signature of a patient's health and could be used to monitor total care of a patient in a superspeciality-integrated in a primary care setting. In doing so, in 2005, Dr. Chaturvedi co-founded the then largest privately held medical center in the Cape Cod region. After initial successes and participation of physicians and surgeons from Boston area hospitals, the center secured funding in excess of $8m to develop a technologically-enhanced urgent care center with additional diagnostics, physical therapy, and ayurvedic spa facilities. Dr. Chaturvedi suffered major setbacks starting in 2007 and lost substantial assets.
TOTAL CARE NETWORK
I n 2007, in wake of decimation of $30m in assets and significant personal and business losses, Dr. Chaturvedi continued to persevere with the idea of deploying affordable, scalable, technologically-integrated, last-mile access to healthcare services, especially by the underserved; on a cross-border, distributed-basis, under the auspices of a startup—Total Care Network. Dr. Chaturvedi traveled to many regions of the world to study and attempt to implement use cases of effective means to provide world-class, benchmarked and quality-driven medical care significantly enhanced with technology.
2009 MOOLEX
I In 2009, Dr. Chaturvedi co-founded Moolex to bring a vast body of experience in startups, technology, applied research, clinical care and the underwriting of insured risk-pools in health maintenance organizations in the United States and create a robust incubation platform across verticals.
ENGINEERING A SMARTER TODAY. INCUBATING A BETTER TOMORROW
Moolex was founded with the idea that the best in humanity must be nurtured and human excellence regardless of station by birth or otherwise influenced by ethnicity, racial divides, political agendas should not stifle human growth. In 2009, Moolex announced Dr. Chaturvedi's invention from 1997 of an algorithmic tokenization construct of a gold-backed digital currency, which could responsibly interchange with a sovereign currency and provide alternative pathways to underserved, disenfranchised populations on earth, who apart from not being able to meet the basic sustenance of life, were forever enslaved in generational technology divides from the first world nations.
JUST SCIENCE, WITHOUT THE HUBRIS
L ord William Thomson Kelvin is rightfully honored by a celebrated measure of temperature by his name. In 1895, Lord Kelvin stated— "Heavier than air machines are impossible". In 1900, Lord Kelvin proclaimed to physicists at an address to the British Association of the Advancement of Science— "There is nothing new to be discovered in Physics..."
1948 MAX PLANCK
Dr. Chaturvedi has often found himself facing strong opposition to his ideas on science, and applied technology; and yet he continues to prevail at the substantial cost of time and angst. Strengthened by adversity, Dr. Chaturvedi remained committed to continue on the path to apply scientific method to create solutions for humanity to thrive. Inspired by Nobel Laureate, Dr. Max Planck's comment in 1948— "A new scientific truth does not triumph by convincing its opponents and making them see the light, but rather because its opponents eventually die, and a new generation grows up that is familiar with it.", Dr. Chaturvedi has chosen to pursue his work without acclaim or debate, and is resolute to let the results speak for themselves, as and when they were achieved.
ON QUANTUM MECHANICS
At the flourish of Quantum Mechanics, Dr. Neils Bohr said in 1952—"Anyone who is not shocked by quantum theory does not understand it." David Mermin (misattributed to Richard Feynman), famous for the exhort—Shut up and calculate—remarked as late as 1965— "I think I can safely say that nobody understands quantum mechanics." In 1942, in an astute observation in a private letter to Cornelius Lanczos at Princeton; Dr. Einstein said—"It seems hard to sneak a look at God's cards. But that He plays dice and uses 'telepathic' methods... is something that I cannot believe for a single moment." Dr. Chaturvedi believes that humanity is on the verge of innovations, inventions and constructs not present in prevalent theories of the sciences and that we may be at a flashpoint of a 21st century renaissance on Earth. The study and modulation of spheons have the potential to represent an equivalent ”Quantum Mechanics“ moment of recent times.
THEORY OF SPHENOME: DETERMINISTIC CAUSALITY
L ord William Thomson Kelvin is rightfully honored by a celebrated measure of temperature by his name. In 1895, Lord Kelvin stated— "Heavier than air machines are impossible". In 1900, Lord Kelvin proclaimed to physicists at an address to the British Association of the Advancement of Science— "There is nothing new to be discovered in Physics..."
A THEORY OF EVERYTHING
Dr. Chaturvedi has postulated a non-string—Theory of Sphenome where is time is a vector. By adding causality vectors to a non-euclidean model of space and time to explain ubiquitous interactions between inorganic and organic signatures of both energy and matter. In a private gathering in late 2011, while proposing a new financial structure for UHNI and distinguished royal family representatives, Dr. Chaturvedi presented several decades of research in a novel, non-traditional construct—Theory of Sphenome—an approach to a theory of everything. Dr. Chaturvedi postulated the existence of naturally present class of over 200 fundamental attoscale particles—Spheons—and began defining their transforms in the properties of structure, function, and energy states— Sphenomenal Transforms. SHF—a framework of heuristics analyses based on principles of non-extensive statistical mechanics—with the ingest of observational or interventional data has allowed the creation of postulates and their derivatives. Concepts and constructs have been used to iteratively validate or improve computational learning and predictive algorithms. A use case example shared in early 2012 utilized sine, logarithmic, and modified non-extensive equations to graph the normal, strained, and injured human heart in vivo.
A casual observation of the real part of the graph may mimic today's EKG output used around the world to evaluate biopotential as it interacts with sensors powered by electricity. For the better part of a decade, a form cardiopulmonary resuscitation, based on the principles of an electrocardiogram is being researched. In theory, this SHF concept allows a modified EKG to improve the efficacy of interventional techniques has the potential to improve 5-year survivals in post-SCD patients. Dr. Chaturvedi has postulated the modulation of spheons in vivo in analytical frameworks of biological processes may help in understanding the hamiltonian-equivalents of living matter. Similar to the advances in science which have continuingly improved machine design and function, using SHF, a better understanding of the mathematics and physics models of the genomic engineering in living matter may allow better treatment and eventual cure of diseases.
SPHENOME HEURISTICS FRAMEWORK (SHF)
D erives from real-world utilization of heuristics based computational intelligence. 108 incubation platforms spanning a wide spectrum of verticals have been fundamentally innovated solution sets and business models. Domain expertise across disciplines of fundamental sciences, arts, architecture, applied research in engineering, biomechanics, genomics, proteomics, astrophysics, air-quality, telecommunications, quantum-safe transaction networks, distributed ledgers, structured finance, central banking, monetary policies, and others has been used to develop knowledgebases. Moolex aims to fast-track an idea or an innovation to sustainable commercialization through Sphenome Research Institute—SphReI—a flagship platform of Moolex.
9/2019 EXPOSURE OF HARM BY A GROUP
S tarting early in 1995, several business ventures started and ramped up by Dr. Chaturvedi and his father would fail after establishing documented success and revenue, both in the US and in India. Dr. Chaturvedi attributed the failures to lack of business acumen. He chalked up the unfortunate loss of a rapidly growing concept of single-location HMO in Cape Cod, with a discounted 5-yr NPV of $100m in 2007, the subsequent fraudulent transactions involving Hartford Stadium, in Connecticut, US, and additional unlawful actions by litigating parties in India as repeated strokes of bad luck. It was not until September 2019, in the pendency of the launch of the 17+1 campaign and several innovations to address the pandemic in calendar 2020, the actions of a group of individuals and entities came in plain sight. Notwithstanding an escalation in extortion, blackmail, and death threats by this group against Dr. Chaturvedi and his family, he decided to seek a final remedy at law. Having survived manifest injustice in two bankruptcy actions, and over 45 lawsuits during the last 15 years and losses in court battles, inspite of substantial legal expense, Dr. Chaturvedi is now beginning to learn the practice of law to prosecute the bad actors himself. Armed with the knowledge, proof, paper-trail and evidence of the harmful actions of this group that has caused significant unlawful harm to Dr. Chaturvedi, his family and his reputation, along with unlawful attacks on his medical license and his various business properties, Dr. Chaturvedi has commenced litigation against this influential group in the US District Court and pending actions in Indian courts.
2020 SHIELDSPACE.AI
S phenome Research Institute began several studies to analyze the origin, pathophysiology, management, clinical manifestations of the pandemic. During the last year and half a heuristics framework has defined postulates and models, which have been continuously refined with published data and various SphReI observational studies. The proposed SphReI-HxVaccine clinical trial platform is designed to study an array of clinical and public health interventions and work towards eliminating the pandemic from Earth. shieldSpace.AI—a platform of Moolex— was launched to create and deploy 5 shields to effectively remedy the pandemic.
THE 21tn U ALLOCATION
O n the occasion of celebrating the 10th annual day of Moolex, Universal Pacific Reserve, a platform of Moolex announced an allocation of 21tn mined digital, quantum safe framework of digital tokens—U. The quantum-safe claim is conditional on deployment of netgrid terrestrial and space-based datastores. The U wallets are now in beta and are fueling the proposed SphReI-HxVaccine global clinical trials platform across 97 countries with a budget-spend of €8tn.